Amy J. Reisinger, Chief Executive Officer Of SteelFusion Clinical Toxicology Laboratory, LLC – Ms. Reisinger studied Biology/Pre-Medicine at The University of North Carolina in Wilmington, North Carolina and completed the Graduate Cardiovascular Perfusion Program at Duquesne University in Pittsburgh, Pennsylvania. Ms. Reisinger began her professional career as an Extra Corporeal Membrane Oxygenator (ECMO) Specialist and Histologist at Children’s Hospital of Pittsburgh, Pennsylvania, where she provided perfusion to neonates and assisted the medical examiner with autopsies. She became a Research Scientist at GlaxoSmithKline, Research Triangle Park, North Carolina, where she provided regulatory support to the pharmaceutical industry.
Ms. Reisinger was responsible for performing the gross and microscopic examinations of animals utilized in toxicology studies as well as evaluating the significance of the anatomic and clinical pathology, as well as organ weight data from such studies. SteelFusion prepares, processes, analyses, validates, reports and conducts research and testing of oral fluid and urine [e.g. A pilot study of the management of mental health services and treatment for abuse (SAMHSA) and deaths]. Enzyme-linked immunosorbent assay (ELISA)Liquid chromatography / mass spectrometry / mass spectrometry (LC-MS / MS).Her company’s structure includes forensic medicine, drugs and alcohol, rehabilitation centers, correctional facilities, services for youth, doctors, workers compensation and employment assessment. Her vision is to become more important in the area of quality assurance and compliance.
Small Business Trendsetters Contributor
Discovering Innovators and Leaders in Business, Technology, Health and Personal Development.